Long-term Interferon-alpha 2A does not induce sustained hematologic remission in younger patients with essential thrombocythemia

Leukemia and Lymphoma

Volumn 36, Issue 1-2, 1999, Pages 123-128

  Bentley, M ^a   Taylor, Kerry ^a   Grigg, A ^b   Kronenberg, H ^c   Gibson, J ^c   Bunce, I ^d   Eliadis, P ^d   Olsen, T ^d   Wright, S ^a   Taylor, D ^a   Rodwell, R ^a  

^a MATER HOSPITAL   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d WESLEY HOSPITAL   (Australia)

Author keywords

Essential thrombocythemi; Interferon; Unmaintained remission

Indexed keywords

ALPHA2A INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; LONG TERM CARE; ONSET AGE; PRIORITY JOURNAL; REMISSION; THROMBOCYTE COUNT; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0033457920     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909145955     Document Type: Article

References (17)

1. Randi, M.L., Tossi, C., Fabris, F., Piccoli, A., Rinaldi, V. and Girolami, A. (1997) Even young patients with essential thrombocythemia are prone to thrombosis. Thrombosis and Haemostasis, June (suppl.), PS 184.
2. Beresi, A., Tefferi, A., Silverstein, M., Petitt, R. and Hoagland, C. (1995) Outcome Analysis of 34 Pregnancies in Women With Essential Thrombocythemia. Archives of Internal Medicine, 155, 1217-1222.
3. Milano, V., Gabrielli, S., Rizzo, N., Vianelli, N. and Gugliotta, L. (1996) Successful treatment of Essential Thrombocythemia in a Pregnancy with Recombinant Interferon-α2a. Journal of Maternal-Fetal Medicine, 5, 74-78.
4. Wadenvik, H., Kutti, J., Ridell, B., Revesz, P. and Jacobsson, S. (1991) The Effect of α-Interferon on Bone Marrow Megakaryocytes and Platelet Production Rate in Essential Thrombocythemia. Blood, 77, 2103-2108.
5. Tefferi, A., Elliott, A., Solberg, A. and Silverstein, N. (1997) New drugs in essential thrombocythemia and polycythemia vera. Blood Reviews, 11, 1-7.
6. Sacchi, S., Gugliotta, L., Papineschi, F., Liberati, A.M., Rupoli, S., Delfini, D., Ruggeri, M., Cavanna, L., Bucalossi, A., Benedetti, E., Ferrandina, C., Vinci, G., Morselli, M. and Torelli, G. (1998) Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone. Leukemia, 12, 289-294.
7. Waysbort, A., Giroux, M., Mansat, V., Teixeira, M., Dumas, J.C. and Puel, J. (1993) Experimental study of transplacental passage of alpha interferon by two assay techniques. Journal of Antimicrobials and Chemotherapeutics, 37, 1232-1237.
8. Reichel, R.O., Linkesch, W. and Schetitska, D. (1992) Therapy with recombinant interferon alpha-2c during unexpected pregnancy in a patient with chronic myeloid leukaemia. British Journal of Haematology, 82, (2), 472-473.
9. Giles, F., Gray, A., Brozovic, M., Grant, I. and Machin, S. (1998) Alpha-Interferon Therapy for Essential Thrombocythaemia (letter). Lancet, (July 9), 70-72.
10. Kasparu, H., Bernhart, M., Krieger, O. and Lutz, D. (1992) Remission may continue after determination of rIFNα-2b treatment for essential thrombocythemia. European Journal of Haematology, 48, 32-36.
11. Sacchi, S., Tabilio, A., Leoni, P., Reccardi, A. and Vecchi, A. (1993) Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term α-IFN treatment. Annals of Hematology, 66, 245-246.
12. Murphy, S., Peterson, P., Iland, H. and Laszlo, J. (1997) Experience of the Polycythemia Vera Study Group with Essential Thrombocythemia: A Final Report on Diagnostic Criteria, Survival, and Leukemic Transition by Treatment. Seminars in Hematology, 34, 29-39.
13. Cortellazzo, S., Viero, P., Finazzi, G., D'Emilio, A., Rodeghieroo, F. and Barbui, T. (1990) Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythaemia. Journal of Clinical Oncology, 8, 556-562.
14. Rametta, V., Ferrara, F., Marattoli, V., Matera, C., Mettivier, V. and Cimino, R. (1991) Recombinant Interferon Alpha-2b as Treatment of Essential Thrombocythaemia. Acta Haematology, 3, 126-129.
15. Kassar, N.E., Hetet, G., Li, Y., Briere, J. and Grandchamp, B. (1995) Clonal analysis of haemopoietic cells in essential thrombocythaemia. British Journal of Haematology, 90, 131-137.
16. Gisslinger, H., Linkesch, W., Fritz, E., Ludwig, H., Chott, A. and Radaszkiewicz, T. (1989) Long-term Interferon Therapy for Thrombocytosis in Myeloproliferative Diseases (letter). Lancet, 634-637.
17. Clemens, M. (1986) Interferons and oncogenes. Nature, 313, 513-532.